Literature DB >> 27506532

Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure.

Wei Deng1, Andrew R Ednie1, Jianyong Qi1,2, Eric S Bennett3.   

Abstract

Dilated cardiomyopathy (DCM), the third most common cause of heart failure, is often associated with arrhythmias and sudden cardiac death if not controlled. The majority of DCM is of unknown etiology. Protein sialylation is altered in human DCM, with responsible mechanisms not yet described. Here we sought to investigate the impact of clinically relevant changes in sialylation on cardiac function using a novel model for altered glycoprotein sialylation that leads to DCM and to chronic stress-induced heart failure (HF), deletion of the sialyltransferase, ST3Gal4. We previously reported that 12- to 20-week-old ST3Gal4 (-/-) mice showed aberrant cardiac voltage-gated ion channel sialylation and gating that contribute to a pro-arrhythmogenic phenotype. Here, echocardiography supported by histology revealed modest dilated and thinner-walled left ventricles without increased fibrosis in ST3Gal4 (-/-) mice starting at 1 year of age. Cardiac calcineurin expression in younger (16-20 weeks old) ST3Gal4 (-/-) hearts was significantly reduced compared to WT. Transverse aortic constriction (TAC) was used as a chronic stressor on the younger mice to determine whether the ability to compensate against a pathologic insult is compromised in the ST3Gal4 (-/-) heart, as suggested by previous reports describing the functional implications of reduced cardiac calcineurin levels. TAC'd ST3Gal4 (-/-) mice presented with significantly reduced systolic function and ventricular dilation that deteriorated into congestive HF within 6 weeks post-surgery, while constricted WT hearts remained well-adapted throughout (ejection fraction, ST3Gal4 (-/-) = 34 ± 5.2 %; WT = 53.8 ± 7.4 %; p < 0.05). Thus, a novel, sialo-dependent model for DCM/HF is described in which clinically relevant reduced sialylation results in increased arrhythmogenicity and reduced cardiac calcineurin levels that precede cardiomyopathy and TAC-induced HF, suggesting a causal link among aberrant sialylation, chronic arrhythmia, reduced calcineurin levels, DCM in the absence of a pathologic stimulus, and stress-induced HF.

Entities:  

Keywords:  Animal models; Arrhythmic heart failure; Calcineurin; Congenital disorders of glycosylation; Dilated cardiomyopathy; Echocardiography; Sialic acid

Mesh:

Substances:

Year:  2016        PMID: 27506532      PMCID: PMC4993109          DOI: 10.1007/s00395-016-0574-1

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  66 in total

Review 1.  Alcohol abuse and glycoconjugate metabolism.

Authors:  Napoleon Waszkiewicz; Sławomir Dariusz Szajda; Anna Zalewska; Agata Szulc; Alina Kępka; Alina Minarowska; Marzena Wojewódzka-Żelezniakowicz; Beata Konarzewska; Sylwia Chojnowska; Jerzy Robert Ladny; Krzysztof Zwierz
Journal:  Folia Histochem Cytobiol       Date:  2012-04-24       Impact factor: 1.698

2.  Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy.

Authors:  Y Zou; Y Hiroi; H Uozumi; E Takimoto; H Toko; W Zhu; S Kudoh; M Mizukami; M Shimoyama; F Shibasaki; R Nagai; Y Yazaki; I Komuro
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

3.  Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy.

Authors:  Junbo Ge; Aijun Sun; Vesa Paajanen; Shijun Wang; Chunxi Su; Zhiyin Yang; Ying Li; Shaochun Wang; Jianguo Jia; Keqiang Wang; Yunzeng Zou; Lizhi Gao; Kun Wang; Zheng Fan
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-04-30

4.  Isoform-specific effects of sialic acid on voltage-dependent Na+ channel gating: functional sialic acids are localized to the S5-S6 loop of domain I.

Authors:  Eric S Bennett
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

5.  Regulated and aberrant glycosylation modulate cardiac electrical signaling.

Authors:  Marty L Montpetit; Patrick J Stocker; Tara A Schwetz; Jean M Harper; Sarah A Norring; Lana Schaffer; Simon J North; Jihye Jang-Lee; Timothy Gilmartin; Steven R Head; Stuart M Haslam; Anne Dell; Jamey D Marth; Eric S Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-07       Impact factor: 11.205

6.  Unusually high concentrations of sialic acids on the surface of vascular endothelia.

Authors:  G V Born; W Palinski
Journal:  Br J Exp Pathol       Date:  1985-10

7.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

8.  Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.

Authors:  J David Barrans; Paul D Allen; Dimitrios Stamatiou; Victor J Dzau; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

9.  Variability, heritability and environmental determinants of human plasma N-glycome.

Authors:  Ana Knezević; Ozren Polasek; Olga Gornik; Igor Rudan; Harry Campbell; Caroline Hayward; Alan Wright; Ivana Kolcic; Niaobh O'Donoghue; Jonathan Bones; Pauline M Rudd; Gordan Lauc
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

10.  Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart.

Authors:  Hiroyuki Nakayama; Benjamin J Wilkin; Ilona Bodi; Jeffery D Molkentin
Journal:  FASEB J       Date:  2006-08       Impact factor: 5.191

View more
  5 in total

1.  Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy.

Authors:  Andrew R Ednie; Wei Deng; Kay-Pong Yip; Eric S Bennett
Journal:  FASEB J       Date:  2018-08-23       Impact factor: 5.191

2.  Intracellular O-linked glycosylation directly regulates cardiomyocyte L-type Ca2+ channel activity and excitation-contraction coupling.

Authors:  Andrew R Ednie; Eric S Bennett
Journal:  Basic Res Cardiol       Date:  2020-09-10       Impact factor: 17.165

3.  A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy.

Authors:  Walinka van Tol; Angel Ashikov; Eckhard Korsch; Nurulamin Abu Bakar; Michèl A Willemsen; Christian Thiel; Dirk J Lefeber
Journal:  JIMD Rep       Date:  2019-09-30

4.  A point-mutation in the C-domain of CMP-sialic acid synthetase leads to lethality of medaka due to protein insolubility.

Authors:  Di Wu; Hiromu Arakawa; Akiko Fujita; Hisashi Hashimoto; Masahiko Hibi; Kiyoshi Naruse; Yasuhiro Kamei; Chihiro Sato; Ken Kitajima
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

5.  Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages.

Authors:  Maren Heimerl; Irina Sieve; Melanie Ricke-Hoch; Sergej Erschow; Karin Battmer; Michaela Scherr; Denise Hilfiker-Kleiner
Journal:  Basic Res Cardiol       Date:  2020-09-25       Impact factor: 17.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.